Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akif Dogan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medicina (Kaunas, Lithuania)|March 29, 2023
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?Hatice Odabas, Akif Dogan, Melike Ozcelik, et al.
World Journal of Urology|June 23, 2023
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experienceGoncagul Akdag, Ozkan Alan, Akif Dogan, et al.
Heliyon|February 6, 2024
Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort studyGoncagul Akdag, Özkan Alan, Akif Dogan, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?Goncagul Akdag, Deniz Isik, Akif Dogan, et al.
Cureus|July 29, 2024
Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive TherapyGoncagul Akdag, Akif Dogan, Sedat Yildirim, et al.
Cancers|July 27, 2024
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC PatientsSedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
The Journal of International Medical Research|January 11, 2026
Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinomaMurat Ayhan, Akif Dogan, Sevinç Hallaç Keser, et al.
Chemotherapy|February 18, 2024
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER StatusGoncagul Akdag, Sedat Yildirim, Akif Dogan, et al.
Scientific Reports|May 27, 2024
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapySedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
Oncology Research and Treatment|April 2, 2024
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World ExperienceNargiz Majidova, Murat Sarı, Fatma Akdag Kahvecioglu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medicina (Kaunas, Lithuania)|March 29, 2023
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?Hatice Odabas, Akif Dogan, Melike Ozcelik, et al.
World Journal of Urology|June 23, 2023
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experienceGoncagul Akdag, Ozkan Alan, Akif Dogan, et al.
Heliyon|February 6, 2024
Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort studyGoncagul Akdag, Özkan Alan, Akif Dogan, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?Goncagul Akdag, Deniz Isik, Akif Dogan, et al.
Cureus|July 29, 2024
Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive TherapyGoncagul Akdag, Akif Dogan, Sedat Yildirim, et al.
Cancers|July 27, 2024
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC PatientsSedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
The Journal of International Medical Research|January 11, 2026
Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinomaMurat Ayhan, Akif Dogan, Sevinç Hallaç Keser, et al.
Chemotherapy|February 18, 2024
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER StatusGoncagul Akdag, Sedat Yildirim, Akif Dogan, et al.
Scientific Reports|May 27, 2024
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapySedat Yildirim, Akif Dogan, Goncagul Akdag, et al.
Oncology Research and Treatment|April 2, 2024
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World ExperienceNargiz Majidova, Murat Sarı, Fatma Akdag Kahvecioglu, et al.
Pageof 2